Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pharmacology|July 21, 2009
Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-alpha human monoclonal antibody, in patients with psoriatic arthritisZhenhua Xu, Thuy Vu, Howard Lee, et al.
The Journal of Rheumatology|October 17, 2007
Association of anemia and physical disability among patients with rheumatoid arthritisChenglong Han, Mahboob U Rahman, Mittie K Doyle, et al.
Cancers|January 21, 2023
Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor SignalingFabiola Cecchi, Karen Rex, Joanna Schmidt, et al.
The Journal of Rheumatology|June 7, 2007
Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritisSudha Visvanathan, Joseph C Marini, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|September 5, 2013
Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: results up to 1 year of the phase 3, randomised, multicentre, double blind, placebo controlled GO-FURTHER trialMichael E Weinblatt, Rene Westhovens, Alan M Mendelsohn, et al.
Pharmaceutics|July 20, 2019
Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary PhospholipidosisAateka Patel, Ewelina Hoffman, Doug Ball, et al.
BMJ Open|July 30, 2024
Feasibility of a new 'balanced binocular viewing' treatment for unilateral amblyopia in children aged 3-8 years (BALANCE): results of a phase 2a randomised controlled feasibility trialAnnegret Hella Dahlmann-Noor, John A Greenwood, Andrew Skilton, et al.
Arthritis and Rheumatism|March 2, 2006
Infliximab treatment maintains employability in patients with early rheumatoid arthritisJosef S Smolen, Chenglong Han, Désirée van der Heijde, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2024
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53αChristopher Roselle, Izumi Horikawa, Linhui Chen, et al.
Arthritis and Rheumatism|November 6, 2004
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trialE William St Clair, Désirée M F M van der Heijde, Josef S Smolen, et al.
Pageof 8